Home Business & Economics Kubas Strategie für einen biotechnologisch-pharmazeutischen Forschungspol – positiver Entwicklungspfad oder Sackgasse?
Article
Licensed
Unlicensed Requires Authentication

Kubas Strategie für einen biotechnologisch-pharmazeutischen Forschungspol – positiver Entwicklungspfad oder Sackgasse?

  • Helmut Nuhn
Published/Copyright: October 21, 2015
Become an author with De Gruyter Brill

Cuba’s research and development strategy in biotechnology and pharmaceutical industries - road to success or dead end? During the last two decades Cuba has developed biotechnology and pharmaceutical industry with high priority. In spite of remarkable scientific progress the expected economic success did not take place so far. The article outlines the specific goals and general framework of the ambitious Cuban development strategy, describes the building up of the cientific cluster of West Havanna and discusses the problems of commercial exploitation of the high-grade medical products. Finally the outcome of Cuban efforts concerning research and development in the field of biotechnology and medicine are evaluated.

Online erschienen: 2015-10-21
Erschienen im Druck: 2003-10-1

© 2015 by Walter de Gruyter Berlin/Boston

Downloaded on 21.1.2026 from https://www.degruyterbrill.com/document/doi/10.1515/zfw.2003.0010/html
Scroll to top button